Trial intelligence / Profile preview

Preoperative diclofenac suppository for opioid use and postoperative nausea and vomiting in maxillofacial surgery

IRCT20200606047664N1Phase 3Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of diclofenac in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Nausea, Vomiting and 1 more. Started Aug 2019; status: completed.

02

Drugs

diclofenac
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on IRCT20200606047664N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200606047664N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call